Search Results
27 results found for "Benjamin Franklin Medal"
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
the prestigious Louis-Jeantet Prize for Medicine 2022 by the Louis-Jeantet Foundation and the 2022 Benjamin Franklin Medal in Chemistry from The Franklin Institute "Huge congratulations to our founder, Carol the prestigious Louis-Jeantet Prize for Medicine 2022 by the Louis-Jeantet Foundation and the 2022 Benjamin Franklin Medal in Chemistry from The Franklin Institute yesterday for contributions to the field of
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
This week's highlight includes congrats to: Madison Walker , Benjamin Myers , et al., for their research
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
The current frontline approach for pain-management is the use of opioid analgesics.
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
findings suggest that parallel pathways independently relay innate threat signals from different sensory modalities about whether and how multi-sensory innate threat cues are integrated and conveyed from each sensory modality lateral parabrachial nucleus in the brainstem respond to multi-sensory threat cues from various sensory modalities
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
week filled with prestigious events, including receiving the British Pharmacological Society Vane Medal
- 📰 GPCR Weekly News, December 4 to 10, 2023
disease, including first that uses CRISPR Pier Vincenzo Piazza, CEO of AELIS FARMA, Honored with Merit Medal
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs) with a novel drug modality
- Sweet taste receptor agonists attenuate macrophage IL‐1β expression and eosinophilic inflammation...
macrophage IL‐1β overproduction, thereby suggesting autophagy regulation as a potential therapeutic modality
- 📰 GPCR Weekly News, October 30 to November 4, 2023
06954522 into a Phase 1 Trial Andrew Hopkins Inducted into RSC BMCS Hall of Fame and Receives Associated Medal
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
fluorescent ligands were effective at monitoring real-time A2BAR receptor labeling using live-imaging modalities
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
R Huxley , Peter Gmeiner , Peter J McCormick , Dorothee Weikert , Masha Y Niv , Moran Shalev-Benami
- 📰 GPCR Weekly News, August 7 to 13, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Want to share your project in a casual way?
- 📰 GPCR Weekly News, March 4 to 10, 2024
with selective and nonselective antagonists studied by NMR spectroscopy Up-regulation of GPR139 in the medial
- 📰 GPCR Weekly News, July 17 to July 23, 2023
GPCR Symposium on GPCRs as Therapeutic Modalities on September 22nd.
- 📰 GPCR Weekly News, August 21 to 27, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities'.
- 📰 GPCR Weekly News, August 14 to 20, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities'.
- 📰 GPCR Weekly News, July 24 to July 30, 2023
GPCR Symposium on GPCRs as Therapeutic Modalities is on September 22nd.
- 📰 GPCR Weekly News, September 18 to 24, 2023
GPCR Symposium about 'GPCRs as Therapeutic Modalities' rocked it!
- 📰 GPCR Weekly News, September 11 to 17, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' with Richa Tyagi, Dr. Terry Kenakin, Dr.
- 📰 GPCR Weekly News, September 4 to 10, 2023
GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video
- 📰 GPCR Weekly News, August 28 to September 3, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' Showcase your project with a 1-minute abstract video
- 📰 GPCR Weekly News, July 31 to August 6, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' is set for September 22nd.
- Chemokine receptor-targeted drug discovery: progress and challenges
Overall, the future potential lies in using different therapeutic modalities to modulate the stromal
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
., Medel-Lacruz, B., Baidya, M., Makarova, M., Mistry, R., Goulding, J., Drube, J., Hoffmann, C., Owen
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Treasures Edelris Announces Research Services Agreement with Pfizer on Targeted Protein Degradation Modalities
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Approval success rates of drug candidates based on target, action, modality, application, and their combinations
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
Platform One way to overcome the challenges presented by small protein GPCRs is to use small proteins as modalities